NO20075404L - Tablett inneholdende steroidhormoner - Google Patents

Tablett inneholdende steroidhormoner

Info

Publication number
NO20075404L
NO20075404L NO20075404A NO20075404A NO20075404L NO 20075404 L NO20075404 L NO 20075404L NO 20075404 A NO20075404 A NO 20075404A NO 20075404 A NO20075404 A NO 20075404A NO 20075404 L NO20075404 L NO 20075404L
Authority
NO
Norway
Prior art keywords
delivery
steroid hormones
minutes
blood
tablet containing
Prior art date
Application number
NO20075404A
Other languages
English (en)
Norwegian (no)
Inventor
Michael Dittgen
Markus Krumme
Albert Radlmaier
Sascha General
Keith Jensen
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36998911&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20075404(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO20075404L publication Critical patent/NO20075404L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20075404A 2005-03-31 2007-10-24 Tablett inneholdende steroidhormoner NO20075404L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005015128A DE102005015128B4 (de) 2005-03-31 2005-03-31 Wafer enthaltend Steroidhormone
PCT/EP2006/002358 WO2006102990A2 (de) 2005-03-31 2006-03-15 Wafer enthaltend steroidhormone

Publications (1)

Publication Number Publication Date
NO20075404L true NO20075404L (no) 2007-12-20

Family

ID=36998911

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075404A NO20075404L (no) 2005-03-31 2007-10-24 Tablett inneholdende steroidhormoner

Country Status (26)

Country Link
US (2) US9763960B2 (cg-RX-API-DMAC7.html)
EP (1) EP1863444B1 (cg-RX-API-DMAC7.html)
JP (2) JP5843416B2 (cg-RX-API-DMAC7.html)
KR (2) KR101428625B1 (cg-RX-API-DMAC7.html)
CN (2) CN101132766A (cg-RX-API-DMAC7.html)
AR (1) AR054245A1 (cg-RX-API-DMAC7.html)
AU (1) AU2006228820B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0609601A2 (cg-RX-API-DMAC7.html)
CA (1) CA2598892C (cg-RX-API-DMAC7.html)
CR (1) CR9468A (cg-RX-API-DMAC7.html)
DE (1) DE102005015128B4 (cg-RX-API-DMAC7.html)
DO (1) DOP2006000070A (cg-RX-API-DMAC7.html)
EA (1) EA014183B1 (cg-RX-API-DMAC7.html)
GT (1) GT200600126A (cg-RX-API-DMAC7.html)
IL (1) IL186081A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007012081A (cg-RX-API-DMAC7.html)
NO (1) NO20075404L (cg-RX-API-DMAC7.html)
NZ (1) NZ592882A (cg-RX-API-DMAC7.html)
PE (1) PE20061194A1 (cg-RX-API-DMAC7.html)
SG (1) SG179459A1 (cg-RX-API-DMAC7.html)
SV (1) SV2008002466A (cg-RX-API-DMAC7.html)
TW (1) TWI393576B (cg-RX-API-DMAC7.html)
UA (1) UA92011C2 (cg-RX-API-DMAC7.html)
UY (1) UY29441A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006102990A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200706116B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8492369B2 (en) 2010-04-12 2013-07-23 Clarus Therapeutics Inc Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
AU2006236564B2 (en) 2005-04-15 2011-02-17 Besins Healthcare Luxembourg S.A.R.L. Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
DE102006027796A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Estrogen-Gestagen-Kombinationen
BRPI0908231A2 (pt) * 2008-02-13 2015-07-21 Bayer Schering Pharma Akltiengesellschaft Sistema de liberação de fármaco com efeito estabilizante
KR20100125309A (ko) * 2008-02-13 2010-11-30 바이엘 쉐링 파마 악티엔게젤샤프트 에스트라디올-함유 약물 전달 시스템
TW201008569A (en) * 2008-08-08 2010-03-01 Bayer Schering Pharma Ag Progestin-containing drug delivery system
JP2012509286A (ja) * 2008-11-21 2012-04-19 バイエル ファーマ アクチエンゲゼルシャフト 薬物送達システム
JP5777170B2 (ja) 2009-10-30 2015-09-09 アイエックス バイオファーマ リミテッド 速溶性固体剤形
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
US10806703B2 (en) * 2012-01-20 2020-10-20 Lts Lohmann Therapie-System Ag Transmucosal administration system for a pharmaceutical drug
WO2014018075A1 (en) 2012-07-23 2014-01-30 Crayola, Llc Dissolvable films and methods of using the same
DE102017112527B4 (de) * 2017-06-07 2019-01-03 Lts Lohmann Therapie-Systeme Ag Schnell zerfallende Schaumwafer mit hohem Flächengewicht
SG11202007303YA (en) * 2018-02-02 2020-08-28 Aytu Bioscience Inc Methods of testosterone therapy

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB981372A (en) * 1960-05-04 1965-01-27 Pfizer Ltd Pharmaceutical formulations for oral administration to animals
US4136162A (en) * 1974-07-05 1979-01-23 Schering Aktiengesellschaft Medicament carriers in the form of film having active substance incorporated therein
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
WO1993023011A1 (en) * 1992-05-18 1993-11-25 Minnesota Mining And Manufacturing Company Transmucosal drug delivery device
DE19646392A1 (de) 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
DE19847252B4 (de) * 1998-10-02 2004-02-12 Jenapharm Gmbh & Co. Kg Bukkal applizierbare bioadhäsive Systeme mit zeitlich gesteuerter Wirkstofffreisetzung enthaltend Testosteronester und fakultativ zusätzlich Testosteron
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
US20030092658A1 (en) * 2001-02-02 2003-05-15 Meyers Rachel E. Novel human enzyme family members and uses thereof
EP1296653A4 (en) * 2000-07-06 2005-09-21 Sarnoff Corp METHOD FOR FORMULATING HYGIENE PRODUCTS WITH IMPROVED STABILITY
WO2005039531A1 (en) * 2003-10-10 2005-05-06 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
GB0100760D0 (en) * 2001-01-11 2001-02-21 Biocompatibles Ltd Drug delivery from stents
US6585997B2 (en) * 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
FR2832311B1 (fr) * 2001-11-21 2004-04-16 Besins Int Belgique Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations
JO2492B1 (en) * 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
JP2007512225A (ja) * 2003-07-31 2007-05-17 アイバックス コーポレイション 脳標的ステロイド薬剤供給系用の経粘膜剤形

Also Published As

Publication number Publication date
MX2007012081A (es) 2007-11-21
KR101428625B1 (ko) 2014-08-13
CA2598892A1 (en) 2006-10-05
EP1863444B1 (de) 2015-12-09
NZ592882A (en) 2012-12-21
BRPI0609601A2 (pt) 2010-04-20
CN104983669B (zh) 2018-05-18
EA200702102A1 (ru) 2008-04-28
US20060222708A1 (en) 2006-10-05
CR9468A (es) 2008-01-21
AR054245A1 (es) 2007-06-13
SV2008002466A (es) 2008-02-08
JP2013155190A (ja) 2013-08-15
US9763960B2 (en) 2017-09-19
US20170348321A1 (en) 2017-12-07
UY29441A1 (es) 2006-10-31
DE102005015128B4 (de) 2008-12-11
IL186081A0 (en) 2008-01-20
TWI393576B (zh) 2013-04-21
GT200600126A (es) 2007-03-14
TW200714299A (en) 2007-04-16
EA014183B1 (ru) 2010-10-29
DOP2006000070A (es) 2007-08-15
UA92011C2 (ru) 2010-09-27
WO2006102990A2 (de) 2006-10-05
EP1863444A2 (de) 2007-12-12
PE20061194A1 (es) 2006-11-23
WO2006102990A3 (de) 2007-03-22
AU2006228820B2 (en) 2011-08-25
CN104983669A (zh) 2015-10-21
AU2006228820A1 (en) 2006-10-05
KR20140063740A (ko) 2014-05-27
KR20080002798A (ko) 2008-01-04
JP5843416B2 (ja) 2016-01-13
DE102005015128A1 (de) 2006-10-05
SG179459A1 (en) 2012-04-27
CN101132766A (zh) 2008-02-27
ZA200706116B (en) 2008-11-26
JP2008534533A (ja) 2008-08-28
CA2598892C (en) 2014-10-14

Similar Documents

Publication Publication Date Title
NO20075404L (no) Tablett inneholdende steroidhormoner
PL379867A1 (pl) Układ dostarczania o kontrolowanym uwalnianiu do podawania donosowego
EA201001244A1 (ru) Система доставки лекарственного средства со стабилизирующим эффектом
ATE374601T1 (de) Multipartikuläre arzneiform, enthaltend mucoadhaesiv formulierte peptid- oder protein- wirkstoffe, sowie ein verfahren zur herstellung der arzneiform
HRP20050077B1 (hr) Postupci i oblici doziranja za kontrolirano oslobađanje paliperidona
ATE496617T1 (de) Abgabesystem mit gesteuerter freisetzung zur nasalen anwendung von neurotransmittern
WO2004054542A3 (en) Oral drug delivery system comprising high viscosity liquid carrier materials
EA200401252A1 (ru) Микрочастицы лекарственных веществ
AR097045A2 (es) Sistema terapéutico transdérmico
ATE302616T1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
CY1107512T1 (el) Νεες υποκατεστημενες με βενζιμιδαζολιο μορφες δοσολογιας και μεθοδος για τη χρηση τους
TW200719915A (en) Flavoring of drug-containing chewing gums
DK1441705T3 (da) Faste, stabiliserede terapeutiske systemer med hurtig og/ellermodificeret frigivelse til oral indgivelse af flydende aktive stoffer,hjælpestoffer eller fødevarer
TR200200562T2 (tr) Vücutta kontrollü şekilde salgılanabilen ve nahoş tadı önleyebilen ağızdan alınmaya mahsus farmasötik bileşimler
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
EA200900264A1 (ru) Композиции флибансерина и способ их приготовления
NO20064874L (no) Kontrollert frigivelses farmasoytisk sammensetning og metode for fremstilling av samme
AR034517A1 (es) Formulacion farmaceutica
ATE361060T1 (de) Ionenstärkenunabhängige pharmazeutische formulierung mit verzögerter freisetzung
AR040737A1 (es) Administracion oral de calcitonina
NO20062668L (no) Orale formuleringer av desoxypeganin og anvendelser derav
DE602004022515D1 (de) Fenofibrate tablett und verfahren zur herstellung
BR9806303A (pt) Sistema de distrituição de droga termoformado, e, unidade de dosagem
PT1275383E (pt) Composicao farmaceutica de libertacao modificada que contem bupropion hc1 como substancia activa

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: LTS LOHMANN THERAPIE-SYSTEME AG, DE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: LTS LOHMANN THERAPIE-SYSTEME AG, DE

FC2A Withdrawal, rejection or dismissal of laid open patent application